
R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi
Nov 24, 2025 · Sanofi is a research & development-driven, AI-powered healthcare biopharmaceutical company committed to improving lives through innovative medicines & …
Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Sanofi - Wikipedia
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops …
Sanofi shares fall on twin trouble for experimental multiple …
15 hours ago · French drugmaker Sanofi on Monday flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis drug and reported disappointing results from a …
Our Company: Committed to Improving People's Lifes | Sanofi
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Our team is guided by one purpose: we chase the miracles of …
Our Company - Sanofi U.S.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare.
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
11 hours ago · Sanofi’s experimental drug for multiple sclerosis (MS) has been hit with another US regulatory delay, a setback compounded by disappointing results from a Phase III trial that …
Sanofi Multiple Sclerosis Drug Hit by Double Setback - WSJ
17 hours ago · Sanofi SAN-0.38%decrease; red down pointing triangle said a U.S. regulatory decision on its tolebrutinib experimental treatment for a type of multiple sclerosis would be …
Our Science - Sanofi
Discover Sanofi's commitment to scientific innovation, our R&D focus areas, product pipeline, and digital approach to transforming the practice of medicine.
Our Products and Resources | Sanofi USA
Sanofi is a diversified global healthcare leader, focused on developing products that meet the health needs of people. We have extensive lines of prescription medicines and vaccines, as …